Cargando…
Interleukin‐6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease, characterized by antinuclear autoantibodies (ANA) and immunocomplexes, commonly affecting kidneys, skin, heart, lung or even the brain. We have shown that JunB(Δep) mice develop a SLE phenotype linked to increased epidermal Interleukin (IL...
Autores principales: | Birner, Peter, Heider, Susanne, Petzelbauer, Peter, Wolf, Peter, Kornauth, Christoph, Kuroll, Madeleine, Merkel, Olaf, Steiner, Günter, Kishimoto, Tadamitsu, Rose‐John, Stefan, Soleiman, Afschin, Moriggl, Richard, Kenner, Lukas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982049/ https://www.ncbi.nlm.nih.gov/pubmed/26739431 http://dx.doi.org/10.1111/exd.12934 |
Ejemplares similares
-
Interleukin-6: discovery of a pleiotropic cytokine
por: Kishimoto, Tadamitsu
Publicado: (2006) -
Selective APRIL Blockade Delays Systemic Lupus Erythematosus in Mouse
por: Huard, Bertrand, et al.
Publicado: (2012) -
Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
por: Tanaka, Toshio, et al.
Publicado: (2012) -
Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms
por: Kang, Sujin, et al.
Publicado: (2021) -
Historical overview of the interleukin-6 family cytokine
por: Kang, Sujin, et al.
Publicado: (2020)